WHAT TO EXPECT FROM YOUR INJECTION EXPERIENCE WITH SIMPONI®

SIMPONI® Dosing: Just One Injection, Once a Month

SIMPONI® requires fewer injections under the skin than the selected anti-TNF biologic medicines in moderate to severe rheumatoid arthritis (RA), active psoriatic arthritis (PsA), and active ankylosing spondylitis (AS). Keep in mind that shown below, while how often you take a medicine matters, there are other important factors to consider. Talk to your doctor about treatment options and what might be right for you.

 

Minimum number of injections first year

Dosing schedule

SIMPONI®*
(golimumab) autoinjector
SIMPONI® (golimumab) 12 doses per year

12

One injection under the skin, once a month

Humira®†ǂ
(adalimumab) pen
SIMPONI® (golimumab) 12 doses per year vs 26 Humira® (adalimumab) pen

26

One injection, under the skin, every other week

Enbrel®ƚ
(etanercept) autoinjector

SIMPONI® (golimumab) 12 doses per year vs 52  Enbrel® (etanercept) autoinjector

52

One injection under the skin, once a week

  Minimum number of injections first year Dosing schedule

SIMPONI®*(golimumab) autoinjector

SIMPONI® (golimumab) 12 doses per year

x 12

One injection under the skin, once a month

Humira®†ǂ(adalimumab) pen

SIMPONI® (golimumab) 12 doses per year vs 26 Humira® (adalimumab) pen

x 26

One injection, under the skin, every other week

Enbrel®ƚ(etanercept) autoinjector

SIMPONI® (golimumab) 12 doses per year vs 52  Enbrel® (etanercept) autoinjector

x 52

One injection under the skin, once a week
  • *SIMPONI® is used with the medicine methotrexate (MTX) for RA treatment and alone or with MTX for PsA treatment.
  • SIMPONI®, Humira®, and Enbrel® are also available in a prefilled syringe.
  • Humira® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. Humira® can be used alone or in combination with MTX or other non-biologic disease-modifying anti-rheumatic drugs (DMARDS).
  • Enbrel® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active RA. Enbrel® can be initiated in combination with MTX or used alone.
  • Trademarks are the property of their respective owners.
  • This presentation is not intended to compare the safety, effectiveness, or uses of these treatments. This information, along with other factors, can be considered with your doctor when discussing treatment options. Please refer to each product's Prescribing Information and Medication Guide for recommended dosing and administration.
  • While dosing may be important, there are other factors to consider. So talk to your doctor about treatment options and what might be right for you.